Phedias Diamandis, MD, PhD, FRCPC

Follow Dr. Diamandis:

Dr. Diamandis completed his combined MD/PhD and residency training in neuropathology at the University of Toronto. His graduate work focused on designing high-throughput screening platforms to chemically profile neural precursors. This research resulted in the identification of novel regulators of neural and cancer stem cell function. Following completion of his training in 2016, he was hired as a Neuropathologist at the University Health Network. Here, his research team focuses on using chemical biology, deep learning and mass spectrometry-based proteomics to resolve phenotype-level heterogeneity in different brain and glioblastoma niches.

Mol Psychiatry. 2019 Aug 23;:
Grenier K, Kao J, Diamandis P
NPJ Digit Med. 2019;2:28
Sarwar S, Dent A, Faust K, Richer M, Djuric U, Van Ommeren R, Diamandis P
Neuro Oncol. 2019 May 11;:
Papaioannou MD, Djuric U, Kao J, Karimi S, Zadeh G, Aldape K, Diamandis P
World Neurosurg. 2019 Jul;127:336-345
Voisin MR, Ovenden C, Tsang DS, Gupta AA, Huang A, Gao AF, Diamandis P, Almeida JP, Gentili F
Crit Rev Clin Lab Sci. 2019 Jan;56(1):61-73
Xie Q, Faust K, Van Ommeren R, Sheikh A, Djuric U, Diamandis P
Neurol Clin. 2018 Aug;36(3):439-447
Diamandis P, Aldape K
NPJ Precis Oncol. 2017;1(1):22
Djuric U, Zadeh G, Aldape K, Diamandis P
BMC Bioinformatics. 2018 May 16;19(1):173
Faust K, Xie Q, Han D, Goyle K, Volynskaya Z, Djuric U, Diamandis P
Mol Cell Proteomics. 2017 Sep;16(9):1548-1562
Djuric U, Rodrigues DC, Batruch I, Ellis J, Shannon P, Diamandis P
J Clin Oncol. 2017 Jul 20;35(21):2386-2393
Diamandis P, Aldape KD


Neuropathologist, University Health Network
Assistant Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto